State Farm Gets CEO Cancer Gold Standard Accreditation

State Farm said that it has received CEO Cancer Gold Standard accreditation, recognizing the organization's commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

William C. Weldon, chairman and chief executive officer of Johnson & Johnson chairs the CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals.

"We are proud of the leadership that State Farm Chairman and CEO, Ed Rust, has demonstrated as a longtime member of the CEO Roundtable on Cancer to promote healthier workplaces," said Weldon. "The CEO Cancer Gold Standard certification recognizes that State Farm's commitment to serving their more than 80 million policies and accounts is matched by a commitment to serve the health and wellness needs of their own employees and family members."

The CEO Cancer Gold Standard calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet, and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.

State Farm is the 43rd organization to become Gold Standard accredited. Other organizations joining State Farm in championing this workplace-based effort to eliminate cancer as a public health threat include: Aetna, the American Cancer Society, the American Legacy Foundation, the American Society of Clinical Oncology, Aptuit, AstraZeneca, C-Change, Cigna, Dana-Farber Cancer Institute, Duke Medicine, Edelman, Enzon Pharmaceuticals, Fox Chase Cancer Center, GHI (an EmblemHealth company), GlaxoSmithKline, Hogan & Hartson, Independence Blue Cross & Blue Shield, Jenner & Block, Johnson & Johnson, The Lance Armstrong Foundation, M. D. Anderson Cancer Center, Millennium: The Takeda Oncology Company, Meridian Health, Minot State University, H. Lee Moffitt Cancer Center and Research Institute, The National Cancer Institute, Novartis, The Oncology Nursing Society, OSI Pharmaceuticals, Pfizer, PhRMA, PPD, Pride, Inc., Quintiles Transnational, sanofi-aventis, SAS Institute, The University of North Dakota, US Oncology, Valeant Pharmaceuticals, Vanderbilt-Ingram Cancer Center, Virtua Health and The Wistar Institute.

((Comments on this story may be sent to health@closeupmedia.com))

Related terms: cancer, ceo, clinical, corporate, family, foundation, gold, health, medicine, millennium, north dakota, nutrition, pharmaceuticals, profit, research, tobacco